DrugCite
Search

NORDETTE

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Nordette Adverse Events Reported to the FDA Over Time

How are Nordette adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Nordette, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Nordette is flagged as the suspect drug causing the adverse event.

Most Common Nordette Adverse Events Reported to the FDA

What are the most common Nordette adverse events reported to the FDA?

Unintended Pregnancy
17 (2.86%)
Drug Exposure During Pregnancy
13 (2.19%)
Drug Ineffective
12 (2.02%)
Drug Interaction
12 (2.02%)
Pregnancy On Oral Contraceptive
11 (1.85%)
Abortion Induced
9 (1.52%)
Anaemia
9 (1.52%)
Headache
8 (1.35%)
Abnormal Withdrawal Bleeding
7 (1.18%)
Cerebral Infarction
7 (1.18%)
Cerebral Venous Thrombosis
7 (1.18%)
Show More Show More
Menorrhagia
7 (1.18%)
Urinary Tract Infection
7 (1.18%)
Cryptorchism
6 (1.01%)
Dysmorphism
6 (1.01%)
Hypotonia Neonatal
6 (1.01%)
Menstruation Irregular
6 (1.01%)
Pulmonary Embolism
6 (1.01%)
Respiratory Disorder
6 (1.01%)
Transient Ischaemic Attack
6 (1.01%)
Amenorrhoea
5 (.84%)
Cerebral Artery Occlusion
5 (.84%)
Cerebrovascular Accident
5 (.84%)
Haemorrhage
5 (.84%)
Hypertension
5 (.84%)
Irritability
5 (.84%)
Menstruation Delayed
5 (.84%)
Pruritus
5 (.84%)
Vaginal Haemorrhage
5 (.84%)
Vomiting
5 (.84%)
Blood Oestrogen Decreased
4 (.67%)
Breast Cancer
4 (.67%)
Carotid Artery Stenosis
4 (.67%)
Chills
4 (.67%)
Drug Administration Error
4 (.67%)
Erythema
4 (.67%)
Feeling Abnormal
4 (.67%)
Inappropriate Schedule Of Drug Admi...
4 (.67%)
Menometrorrhagia
4 (.67%)
Metrorrhagia
4 (.67%)
Oligomenorrhoea
4 (.67%)
Poor Quality Drug Administered
4 (.67%)
Surgery
4 (.67%)
Swelling
4 (.67%)
Weight Increased
4 (.67%)
Abdominal Pain
3 (.51%)
Abortion Spontaneous
3 (.51%)
Alanine Aminotransferase Increased
3 (.51%)
Anxiety
3 (.51%)
Aspartate Aminotransferase Increase...
3 (.51%)
Carotid Artery Dissection
3 (.51%)
Cerebral Artery Embolism
3 (.51%)
Condition Aggravated
3 (.51%)
Dysphagia
3 (.51%)
Ecchymosis
3 (.51%)
Gamma-glutamyltransferase Increased
3 (.51%)
Hydrocephalus
3 (.51%)
Hypoaesthesia
3 (.51%)
Ischaemic Stroke
3 (.51%)
Jaundice
3 (.51%)
Malaise
3 (.51%)
Maternal Drugs Affecting Foetus
3 (.51%)
Memory Impairment
3 (.51%)
Menstrual Disorder
3 (.51%)
Musculoskeletal Stiffness
3 (.51%)
Neck Pain
3 (.51%)
Papilloedema
3 (.51%)
Systemic Lupus Erythematosus
3 (.51%)
Thrombosis
3 (.51%)
Uterine Disorder
3 (.51%)
Uterine Leiomyoma
3 (.51%)
Weight Decreased
3 (.51%)
Abnormal Behaviour
2 (.34%)
Arthralgia
2 (.34%)
Asthenia
2 (.34%)
Blood Cholesterol Increased
2 (.34%)
Blood Pressure Increased
2 (.34%)
Brain Herniation
2 (.34%)
Cerebral Artery Stenosis
2 (.34%)
Cerebral Ischaemia
2 (.34%)
Cholelithiasis
2 (.34%)
Colour Blindness
2 (.34%)
Constipation
2 (.34%)
Convulsion
2 (.34%)
Cyst
2 (.34%)
Cytolytic Hepatitis
2 (.34%)
Depression
2 (.34%)
Diarrhoea
2 (.34%)
Dizziness
2 (.34%)
Dysmenorrhoea
2 (.34%)
Dysphasia
2 (.34%)
Dyspnoea
2 (.34%)
Erythema Nodosum
2 (.34%)
Gallbladder Disorder
2 (.34%)
Haematocrit Decreased
2 (.34%)
Haemolytic Anaemia
2 (.34%)
Histiocytosis Haematophagic
2 (.34%)
Hyperbilirubinaemia
2 (.34%)
Hypothyroidism
2 (.34%)
Impaired Driving Ability
2 (.34%)
Impaired Work Ability
2 (.34%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Nordette, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Nordette is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Nordette

What are the most common Nordette adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Nordette, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Nordette is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Nordette According to Those Reporting Adverse Events

Why are people taking Nordette, according to those reporting adverse events to the FDA?

Contraception
159
Oral Contraception
71
Product Used For Unknown Indication
23
Menorrhagia
8
Drug Use For Unknown Indication
8
Dysmenorrhoea
6
Show More Show More
Hormone Replacement Therapy
5
Menstruation Irregular
5
Gonadotrophin Deficiency
3
Contraceptive Cap
2
Hypogonadism
1
Maternal Exposure During Pregnancy
1
Unevaluable Event
1
Metrorrhagia
1
Migraine
1
Menstrual Disorder
1
Menopausal Symptoms
1
Asthma
1

Drug Labels

LabelLabelerEffective
NordetteTeva Women's Health, Inc.08-OCT-10

Nordette Case Reports

What Nordette safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Nordette. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Nordette.